Literature DB >> 22228071

Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma.

Nicolas F Schlecht1, Margaret Brandwein-Gensler, Richard V Smith, Nicole Kawachi, Darcy Broughel, Juan Lin, Christian E Keller, Paul A Reynolds, Frank J Gunn-Moore, Thomas Harris, Geoffrey Childs, Thomas J Belbin, Michael B Prystowsky.   

Abstract

Members of the 4.1 superfamily of proteins, including ezrin, moesin, merlin, and willin regulate many normal physiologic processes such as cellular shape, motility, and proliferation. In addition, they contribute both to tumor development and tumor progression. We reported previously that strong cytoplasmic ezrin expression was independently associated with poorer patient survival. One hundred and thirty-one histologically confirmed primary head and neck squamous cell carcinomas were examined prospectively for cancer progression and survival at a large health care center in the Bronx, NY, USA. Immunohistochemical analysis of ezrin, moesin, merlin, and willin expression in tissue microarray samples of primary head and neck squamous cell carcinoma revealed a significant association of increased cytoplasmic ezrin with poor cancer survival. Global RNA analyses suggest that cancers with high cytoplasmic ezrin have a more invasive phenotype. This study supports our previous findings associating cytoplasmic ezrin with more aggressive behavior and poorer outcome and indicates the need for a multi-institutional study to validate the use of cytoplasmic ezrin as a biomarker for treatment planning in head and neck squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228071      PMCID: PMC3370015          DOI: 10.1007/s12105-011-0328-1

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  49 in total

1.  Identifiability, exchangeability, and epidemiological confounding.

Authors:  S Greenland; J M Robins
Journal:  Int J Epidemiol       Date:  1986-09       Impact factor: 7.196

2.  Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.

Authors:  Jiro Fujimoto; Ikumi Aoki; Hiroshi Toyoki; Sufia Khatun; Eriko Sato; Hideki Sakaguchi; Teruhiko Tamaya
Journal:  Oncology       Date:  2004       Impact factor: 2.935

3.  Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma.

Authors:  Hiroichi Kobayashi; Junji Sagara; Junya Masumoto; Hiroshi Kurita; Kenji Kurashina; Shuníichiro Taniguchi
Journal:  J Oral Pathol Med       Date:  2003-07       Impact factor: 4.253

4.  Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma.

Authors:  Hiroichi Kobayashi; Junji Sagara; Hiroshi Kurita; Masayo Morifuji; Masamichi Ohishi; Kenji Kurashina; Shun'ichiro Taniguchi
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

5.  Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases.

Authors:  Hila Toledano-Katchalski; Judith Kraut; Tal Sines; Shira Granot-Attas; Galit Shohat; Hava Gil-Henn; Yuval Yung; Ari Elson
Journal:  Mol Cancer Res       Date:  2003-05       Impact factor: 5.852

Review 6.  Localization of receptor-mediated signal transduction pathways: the inside story.

Authors:  Jason M Haugh
Journal:  Mol Interv       Date:  2002-09

7.  CRB3 binds directly to Par6 and regulates the morphogenesis of the tight junctions in mammalian epithelial cells.

Authors:  Céline Lemmers; Didier Michel; Lydie Lane-Guermonprez; Marie-Hélène Delgrossi; Emmanuelle Médina; Jean-Pierre Arsanto; André Le Bivic
Journal:  Mol Biol Cell       Date:  2004-01-12       Impact factor: 4.138

8.  Differential expression of the microspike-associated protein moesin in human tissues.

Authors:  R Schwartz-Albiez; A Merling; H Spring; P Möller; K Koretz
Journal:  Eur J Cell Biol       Date:  1995-07       Impact factor: 4.492

9.  Ezrin, a key component in tumor metastasis.

Authors:  Kent W Hunter
Journal:  Trends Mol Med       Date:  2004-05       Impact factor: 11.951

10.  Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells.

Authors:  M Berryman; Z Franck; A Bretscher
Journal:  J Cell Sci       Date:  1993-08       Impact factor: 5.285

View more
  16 in total

1.  Apolipoprotein E Promotes Invasion in Oral Squamous Cell Carcinoma.

Authors:  Sangeeta K Jayakar; Olivier Loudig; Margaret Brandwein-Gensler; Ryung S Kim; Thomas J Ow; Berrin Ustun; Thomas M Harris; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall; Thomas J Belbin
Journal:  Am J Pathol       Date:  2017-07-24       Impact factor: 4.307

2.  Crumbs 3b promotes tight junctions in an ezrin-dependent manner in mammalian cells.

Authors:  Andrew M Tilston-Lünel; Kathryn E Haley; Nicolas F Schlecht; Yanhua Wang; Abigail L D Chatterton; Susana Moleirinho; Ailsa Watson; Harinder S Hundal; Michael B Prystowsky; Frank J Gunn-Moore; Paul A Reynolds
Journal:  J Mol Cell Biol       Date:  2016-10-01       Impact factor: 6.216

3.  Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer.

Authors:  Agnes Assao; Suely Nonogaki; José Roberto Pereira Lauris; André Lopes Carvalho; Clóvis Antônio Lopes Pinto; Fernando Augusto Soares; Luiz Paulo Kowalski; Denise Tostes Oliveira
Journal:  Clin Oral Investig       Date:  2016-09-14       Impact factor: 3.573

4.  ß1 integrin binding phosphorylates ezrin at T567 to activate a lipid raft signalsome driving invadopodia activity and invasion.

Authors:  Ester Antelmi; Rosa A Cardone; Maria R Greco; Rosa Rubino; Francesca Di Sole; Nicola A Martino; Valeria Casavola; Marialuisa Carcangiu; Loredana Moro; Stephan J Reshkin
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

5.  Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one.

Authors:  Federica Ciregia; Laura Giusti; Angelo Molinaro; Filippo Niccolai; Patrizia Agretti; Teresa Rago; Giancarlo Di Coscio; Paolo Vitti; Fulvio Basolo; Pietro Iacconi; Massimo Tonacchera; Antonio Lucacchini
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

6.  Are podoplanin and ezrin involved in the invasion process of the ameloblastomas?

Authors:  Y F Costa; K C Tjioe; S Nonogaki; F A Soares; J R Pereira Lauris; D Tostes Oliveira
Journal:  Eur J Histochem       Date:  2015-02-24       Impact factor: 3.188

7.  Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma.

Authors:  Shota Saito; Hiroto Yamamoto; Ken-ichi Mukaisho; Sho Sato; Tomoki Higo; Takanori Hattori; Gaku Yamamoto; Hiroyuki Sugihara
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

8.  Prognostic value of Ezrin in solid tumors: a meta-analysis of the literature.

Authors:  Kun Han; WeiXiang Qi; ZhiHua Gan; Zan Shen; Yang Yao; DaLiu Min
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

9.  The relationship between ezrin and podoplanin expressions in keratocystic odontogenic tumors.

Authors:  Denise Tostes Oliveira; Laís Priscila de Santis; Agnes Assao; Kellen Cristine Tjioe; Suely Nonogaki; José Roberto Pereira Lauris; Fernando Augusto Soares
Journal:  BMC Oral Health       Date:  2014-12-05       Impact factor: 2.757

10.  Prognostic Value of Ezrin in Various Cancers: A Systematic Review and Updated Meta-analysis.

Authors:  Jianwei Li; Kuanhai Wei; Hailang Yu; Dan Jin; Gang Wang; Bin Yu
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.